Try our Advanced Search for more refined results
Heron Therapeutics Inc.
-
Order | Filed: May 31, 2024 | Entered: May 31, 2024 HERON THERAPEUTICS, INC. v. SLAYBACK PHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Order
LETTER ORDER granting 41 Joint Request for a two (2) week extension, until 6/13/2024, to file a proposed Confidentiality Order. Signed by Magistrate Judge Michael A. Hammer on 5/31/2024. (dam)
-
Misc | Filed: May 30, 2024 | Entered: May 30, 2024 HERON THERAPEUTICS, INC. v. SLAYBACK PHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Letter
Letter from Plaintiff to the Hon. Michael A. Hammer, U.S.M.J.. (LIZZA, CHARLES)
-
Utility | Filed: May 29, 2024 | Entered: May 29, 2024 HERON THERAPEUTICS, INC. v. SLAYBACK PHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Remark (public)
Remark: D.E. 40 is only a Text Order. (jqb, )
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login